Inventor · disambiguated record
Ryan M. Moslin
Also filed as: MOSLIN RYAN M
16 granted patents·8 pending applications·179 citations·filing 2013–2025
93Inventor score
Files withBRISTOL MYERS SQUIBB CO24
Top patents by PatentIndex Score
24 records- 0198US11866414B2Substituted heterocyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Jan 9, 2024·11 cites·23 claims
- 0297US9505748B2Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responsesBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Nov 29, 2016·53 cites·9 claims
- 0396US11021475B2Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responsesBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jun 1, 2021·8 cites·16 claims
- 0496US10000480B2Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responsesBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jun 19, 2018·20 cites·14 claims
- 0595US11021462B2Sulfone pyridine alkyl amide-substituted heteroaryl compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jun 1, 2021·6 cites·28 claims
- 0694US11787779B2Sulfone pyridine alkyl amide-substituted heteroaryl compoundsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Oct 17, 2023·2 cites·4 claims
- 0794USRE47929EAmide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responsesBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 7, 2020·19 cites·39 claims
- 0892US9663467B2Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responsesBRISTOL MYERS SQUIBB CO·Filed 2014·Granted May 30, 2017·21 cites·7 claims
- 0990US9987266B2Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responsesBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jun 5, 2018·9 cites·1 claims
- 1088US9315494B2Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responsesBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 19, 2016·14 cites·11 claims
- 1187US9540333B2Alkyl amide-substituted pyrimidine compounds useful in the modulation of IL-12, IL-23 and/or IFNαBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 10, 2017·11 cites·16 claims
- 1287US2025243193A1Amide-substituted heterocyclic compounds useful as modulators of il-12, il-23 and/or ifn alpha responsesBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 1386US12365667B2Sulfone pyridine alkyl amide-substituted heteroaryl compoundsBRISTOL MYERS SQUIBB CO·Filed 2023·Granted Jul 22, 2025·0 cites·13 claims
- 1483US2025304555A1Sulfone pyridine alkyl amide-substituted heteroaryl compoundsBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 1582US2025163004A1Substituted heterocyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 1679US10273237B2Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN-α responsesBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Apr 30, 2019·4 cites·2 claims
- 1779US2024190829A1Substituted heterocyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1876US2022356180A1Amide-substituted heterocyclic compounds useful as modulators of il-12, il-23 and/or ifn alpha responsesBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 1975US11884650B2Substituted heterocyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Jan 30, 2024·0 cites·6 claims
- 2075US2024124421A1Substituted heterocyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 2168US10479793B2Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responsesBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Nov 19, 2019·1 cites·3 claims
- 2260US2024317718A1Substituted heterocyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 2359US2025066322A1Substituted heterocyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 2451US12240840B2Amide-substituted heterocyclic compounds for the treatment of conditions related to the modulation of IL-12, IL-23 and/or IFN-alphaBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Mar 4, 2025·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Ryan M. Moslin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →